Finoriq research workspace

Schrodinger, Inc. (SDGR) Insider Transactions & Form 4 Activity

Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for Schrodinger, Inc. (SDGR).

Company Snapshot

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Company

Schrodinger, Inc. (SDGR)

Ticker

SDGR

Market Cap

$1.1B

Latest Price

$15.19

Industry

Biotech & Pharma

Open company research

Schrodinger, Inc. (SDGR) Recent Insider Transactions

Recent market insider transaction records indexed for Schrodinger, Inc. (SDGR).

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.